Shopping Cart
- Remove All
- Your shopping cart is currently empty
hAChE-IN-3 (compound 5c) serves as a potent inhibitor for AChE, BuChE, MAO-B, and BACE-1, with respective IC50 values of 0.44, 0.08, 5.15, and 0.38 μM, demonstrating its ability to cross the blood-brain barrier. This compound also exhibits antioxidant properties and metal chelation capabilities. Additionally, it targets peripheral anion sites, potentially modulating β-amyloid and ameliorating neurodegeneration linked to Alzheimer's disease, highlighting its research potential for this condition [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | hAChE-IN-3 (compound 5c) serves as a potent inhibitor for AChE, BuChE, MAO-B, and BACE-1, with respective IC50 values of 0.44, 0.08, 5.15, and 0.38 μM, demonstrating its ability to cross the blood-brain barrier. This compound also exhibits antioxidant properties and metal chelation capabilities. Additionally, it targets peripheral anion sites, potentially modulating β-amyloid and ameliorating neurodegeneration linked to Alzheimer's disease, highlighting its research potential for this condition [1]. |
Targets&IC50 | MAO-B:5.15 μM, AChE:0.44 μM, BChE:0.08 μM |
In vitro | hAChE-IN-3 (compound 5c) exhibits an IC50 of 36.28 μM in the SH-SY5Y cell line after 24 hours and an IC50 of 154.10 μM in the HepG2 cell line after 48 hours [1]. Additionally, hAChE-IN-3 demonstrates an IC50 of 2.58 μM against β-amyloid plaque aggregation with an inhibition rate of 59% at 10 μM [1]. |
Molecular Weight | 541.98 |
Formula | C30H24ClN3O5 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.